Skip to content
ClinCalc Pro
Menu
Alkalising Agent / Electrolyte

Sodium Bicarbonate

Brand names: Minijet Sodium Bicarbonate, Sodium Bicarbonate 8.4%

Used in: Acute Kidney Injury Poisoning & Overdose Hyperkalaemia

Sodium bicarbonate is an alkalinising agent used intravenously to treat severe metabolic acidosis and, in specific settings, to manage hyperkalaemia and certain drug toxicities.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Bicarbonate ions buffer excess hydrogen ions, raising blood pH, while also promoting an intracellular shift of potassium.

Prescribing in practice

  • Rapid or excessive administration can cause metabolic alkalosis, hypokalaemia, hypernatraemia, fluid overload and a fall in ionised calcium, so it should be reserved for clearly indicated severe acidosis.
  • It is hypertonic and irritant, and extravasation can cause tissue damage; large-vein or central administration is preferred for concentrated solutions.
  • It is incompatible with calcium-containing solutions and many other drugs, which may precipitate in the line.

Monitoring

Monitor arterial blood gases, serum electrolytes including potassium and sodium, and acid-base status during therapy.

Counselling the patient

  • Inform the team that the infusion site should be checked for extravasation.
  • Advise that potassium and pH are rechecked to guide further dosing.

Evidence & guidelines

Its role is supported by acute care and resuscitation guidance, which generally restricts use to severe acidosis and specific indications rather than routine correction.

Reference: Resuscitation Council UK ALS 2021; TOXBASE; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.